{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:17:57Z","timestamp":1780975077876,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T00:00:00Z","timestamp":1200355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s11307-007-0127-y","type":"journal-article","created":{"date-parts":[[2008,1,14]],"date-time":"2008-01-14T16:21:11Z","timestamp":1200327671000},"page":"74-81","source":"Crossref","is-referenced-by-count":46,"title":["FDG-PET\/CT in the Evaluation of Cutaneous T-Cell Lymphoma"],"prefix":"10.1007","volume":"10","author":[{"given":"Phillip H.","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"McClennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacie","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Edelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Heald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,15]]},"reference":[{"key":"127_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1023\/A:1008486928190","volume":"9","author":"M Bangerter","year":"1998","unstructured":"Bangerter M, Moog F, Buchmann I, et al. (1998) Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin\u2019s disease. Ann Oncol 9:1117\u20131122","journal-title":"Ann Oncol"},{"key":"127_CR2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/978-3-642-57054-4_10","volume":"156","author":"I Buchmann","year":"2000","unstructured":"Buchmann I, Moog F, Schirrmeister H, Reske SN (2000) Positron emission tomography for detection and staging of malignant lymphoma. Recent Results Cancer Res 156:78\u201389","journal-title":"Recent Results Cancer Res"},{"key":"127_CR3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1097-0142(20010301)91:5<889::AID-CNCR1078>3.0.CO;2-5","volume":"91","author":"I Buchmann","year":"2001","unstructured":"Buchmann I, Reinhardt M, Elsner K, et al. (2001) 2-(Fluorine-18)fluoro-2-deoxy-d-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 91:889\u2013899","journal-title":"Cancer"},{"key":"127_CR4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.semnuclmed.2005.02.004","volume":"35","author":"G Jerusalem","year":"2005","unstructured":"Jerusalem G, Hustinx R, Beguin Y, Fillet G (2005) Evaluation of therapy for lymphoma. Semin Nucl Med 35:186\u2013196","journal-title":"Semin Nucl Med"},{"key":"127_CR5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00001622-200403000-00003","volume":"16","author":"YL Kasamon","year":"2004","unstructured":"Kasamon YL, Wahl RL, Swinnen LJ (2004) FDG PET and high-dose therapy for aggressive lymphomas: toward a risk-adapted strategy. Curr Opin Oncol 16:100\u2013105","journal-title":"Curr Opin Oncol"},{"key":"127_CR6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.203.3.9169707","volume":"203","author":"F Moog","year":"1997","unstructured":"Moog F, Bangerter M, Diederichs CG, et al. (1997) Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-d-glucose (FDG) PET in nodal staging. Radiology 203:795\u2013800","journal-title":"Radiology"},{"key":"127_CR7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1200\/JCO.1998.16.2.603","volume":"16","author":"F Moog","year":"1998","unstructured":"Moog F, Bangerter M, Kotzerke J, Guhlmann A, Frickhofen N, Reske SN (1998) 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 16:603\u2013609","journal-title":"J Clin Oncol"},{"key":"127_CR8","first-page":"325","volume":"33","author":"J Okada","year":"1992","unstructured":"Okada J, Yoshikawa K, Itami M, et al. (1992) Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. J Nucl Med 33:325\u2013329","journal-title":"J Nucl Med"},{"key":"127_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bmt.1703607","volume":"30","author":"U Cremerius","year":"2002","unstructured":"Cremerius U, Fabry U, Wildberger JE, et al. (2002) Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin\u2019s lymphoma. Bone Marrow Transplant 30:103\u2013111","journal-title":"Bone Marrow Transplant"},{"key":"127_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1008357126404","volume":"12","author":"M Wit de","year":"2001","unstructured":"de Wit M, Bohuslavizki KH, Buchert R, Bumann D, Clausen M, Hossfeld DK (2001) 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin\u2019s lymphoma. Ann Oncol 12:29\u201337","journal-title":"Ann Oncol"},{"key":"127_CR11","first-page":"1225","volume":"44","author":"C Guay","year":"2003","unstructured":"Guay C, Lepine M, Verreault J, Benard F (2003) Prognostic value of PET using 18F-FDG in Hodgkin\u2019s disease for posttreatment evaluation. J Nucl Med 44:1225\u20131231","journal-title":"J Nucl Med"},{"key":"127_CR12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/10428190009113384","volume":"39","author":"NG Mikhaeel","year":"2000","unstructured":"Mikhaeel NG, Timothy AR, O\u2019Doherty MJ, Hain S, Maisey MN (2000) 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin\u2019s lymphoma\u2014comparison with CT. Leuk Lymphoma 39:543\u2013553","journal-title":"Leuk Lymphoma"},{"key":"127_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF03164996","volume":"8","author":"J Okada","year":"1994","unstructured":"Okada J, Oonishi H, Yoshikawa K, et al. (1994) FDG-PET for predicting the prognosis of malignant lymphoma. Ann Nucl Med 8:187\u2013191","journal-title":"Ann Nucl Med"},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2002-12-3842","volume":"102","author":"K Spaepen","year":"2003","unstructured":"Spaepen K, Stroobants S, Dupont P, et al. (2003) Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation. Blood 102:53\u201359","journal-title":"Blood"},{"key":"127_CR15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.mibio.2004.08.004","volume":"6","author":"M Allen-Auerbach","year":"2004","unstructured":"Allen-Auerbach M, Quon A, Weber WA, et al. (2004) Comparison between 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography and positron emission tomography\/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol 6:411\u2013416","journal-title":"Mol Imaging Biol"},{"key":"127_CR16","first-page":"1369","volume":"41","author":"T Beyer","year":"2000","unstructured":"Beyer T, Townsend DW, Brun T, et al. (2000) A combined PET\/CT scanner for clinical oncology. J Nucl Med 41:1369\u20131379","journal-title":"J Nucl Med"},{"key":"127_CR17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1148\/radiol.2352040134","volume":"235","author":"BFIV Branstetter","year":"2005","unstructured":"Branstetter BFIV, Blodgett TM, Zimmer LA, et al. (2005) Head and neck malignancy: is PET\/CT more accurate than PET or CT alone? Radiology 235:580\u2013586","journal-title":"Radiology"},{"key":"127_CR18","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s00259-004-1593-y","volume":"31","author":"P Reinartz","year":"2004","unstructured":"Reinartz P, Wieres F-J, Schneider W, Schur A, Buell U (2004) Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET\/CT? Eur J Nucl Med Mol Imaging 31:1456\u20131461","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"127_CR19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1148\/radiol.2323030985","volume":"232","author":"NG Schaefer","year":"2004","unstructured":"Schaefer NG, Hany TF, Taverna C, et al. (2004) Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging\u2014do we need contrast\u2014enhanced CT? Radiology 232:823\u2013829","journal-title":"Radiology"},{"key":"127_CR20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1148\/radiol.2382041977","volume":"238","author":"GK Schulthess von","year":"2006","unstructured":"von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET\/CT: current applications and future directions. Radiology 238:405\u2013422","journal-title":"Radiology"},{"key":"127_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rcl.2004.07.005","volume":"43","author":"H Zhuang","year":"2005","unstructured":"Zhuang H, Yu JQ, Alavi A (2005) Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol Clin North Am 43:121\u2013134","journal-title":"Radiol Clin North Am"},{"key":"127_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.semnuclmed.2004.06.006","volume":"34","author":"G El-Haddad","year":"2004","unstructured":"El-Haddad G, Zhuang H, Gupta N, Alavi A (2004) Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med 34:313\u2013329","journal-title":"Semin Nucl Med"},{"key":"127_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semnuclmed.2003.09.007","volume":"34","author":"A Alavi","year":"2004","unstructured":"Alavi A, Kung JW, Zhuang H (2004) Implications of PET based molecular imaging on the current and future practice of medicine. Semin Nucl Med 34:56\u201369","journal-title":"Semin Nucl Med"},{"key":"127_CR24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1067\/mjd.2002.124076","volume":"47","author":"M Shapiro","year":"2002","unstructured":"Shapiro M, Yun M, Junkins-Hopkins JM, et al. (2002) Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas. J Am Acad Dermatol 47:623\u2013628","journal-title":"J Am Acad Dermatol"},{"key":"127_CR25","first-page":"115","volume":"89","author":"J Valencak","year":"2004","unstructured":"Valencak J, Becherer A, Der-Petrossian M, Trautinger F, Raderer M, Hoffmann M (2004) Positron emission tomography with [18F] 2-fluoro-d-2-deoxyglucose in primary cutaneous T-cell lymphomas. Haematologica 89:115\u2013116","journal-title":"Haematologica"},{"key":"127_CR26","first-page":"577","volume":"142","author":"EY Tsai","year":"2006","unstructured":"Tsai EY, Taur A, Espinosa L, et al. (2006) Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol 142:577\u2013584","journal-title":"Arch Dermatol"},{"key":"127_CR27","first-page":"561","volume":"63","author":"SI Lamberg","year":"1979","unstructured":"Lamberg SI, Bunn PA Jr (1979) Proceedings of the Workshop on Cutaneous T-Cell Lymphomas (mycosis fungoides and sezary syndrome). Introduction. Cancer Treat Rep 63:561\u2013564","journal-title":"Cancer Treat Rep"},{"key":"127_CR28","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","volume":"350","author":"M Girardi","year":"2004","unstructured":"Girardi M, Heald PW, Wilson LD (2004) The pathogenesis of mycosis fungoides. N Engl J Med 350:1978\u20131988","journal-title":"N Engl J Med"},{"key":"127_CR29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","volume":"115","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Hess S, Richardson SK, et al. (2005) Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 115:798\u2013812","journal-title":"J Clin Invest"},{"key":"127_CR30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1473-0502(02)00014-9","volume":"26","author":"CL Berger","year":"2002","unstructured":"Berger CL, Hanlon D, Kanada D, Girardi M, Edelson RL (2002) Transimmunization, a novel approach for tumor immunotherapy. Transfus Apher Sci 26:205\u2013216","journal-title":"Transfus Apher Sci"},{"key":"127_CR31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.2001.tb03715.x","volume":"941","author":"CL Berger","year":"2001","unstructured":"Berger CL, Longley J, Hanlon D, Girardi M, Edelson R (2001) The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma. Ann N Y Acad Sci 941:106\u2013122","journal-title":"Ann N Y Acad Sci"},{"key":"127_CR32","first-page":"217","volume":"20","author":"CL Berger","year":"2004","unstructured":"Berger CL, Mariwalla K, Girardi M, Edelson RL (2004) Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma. Adv Dermatol 20:217\u2013235","journal-title":"Adv Dermatol"},{"key":"127_CR33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/153303460200100109","volume":"1","author":"M Girardi","year":"2002","unstructured":"Girardi M, Berger C, Hanlon D, Edelson RL (2002) Efficient tumor antigen loading of dendritic antigen presenting cells by transimmunization. Technol Cancer Res Treat 1:65\u201369","journal-title":"Technol Cancer Res Treat"},{"key":"127_CR34","first-page":"1061","volume":"14","author":"M Girardi","year":"2000","unstructured":"Girardi M, Edelson RL (2000) Cutaneous T-cell lymphoma: pathogenesis and treatment. Oncology (Williston Park) 14:1061\u20131070; discussion 1070\u20131064, 1076","journal-title":"Oncology (Williston Park)"},{"key":"127_CR35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0733-8635(05)70190-X","volume":"18","author":"M Girardi","year":"2000","unstructured":"Girardi M, Heald PW (2000) Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology. Dermatol Clin 18:417\u2013423, viii","journal-title":"Dermatol Clin"},{"key":"127_CR36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0889-8588(03)00106-0","volume":"17","author":"M Girardi","year":"2003","unstructured":"Girardi M, Knobler R, Edelson R (2003) Selective immmunotherapy through extracorporeal photochemotherapy: yesterday, today, and tomorrow. Hematol Oncol Clin North Am 17:1391\u20131403","journal-title":"Hematol Oncol Clin North Am"},{"key":"127_CR37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0923-1811(98)00066-8","volume":"19","author":"M Girardi","year":"1999","unstructured":"Girardi M, McNiff JM, Heald PW (1999) Extracorporeal photochemotherapy in human and murine graft-versus-host disease. J Dermatol Sci 19:106\u2013113","journal-title":"J Dermatol Sci"},{"key":"127_CR38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-0502(02)00011-3","volume":"26","author":"M Girardi","year":"2002","unstructured":"Girardi M, Schechner J, Glusac E, Berger C, Edelson R (2002) Transimmunization and the evolution of extracorporeal photochemotherapy. Transfus Apher Sci 26:181\u2013190","journal-title":"Transfus Apher Sci"},{"key":"127_CR39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2001.tb03716.x","volume":"941","author":"R Knobler","year":"2001","unstructured":"Knobler R, Girardi M (2001) Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas. Ann N Y Acad Sci 941:123\u2013138","journal-title":"Ann N Y Acad Sci"},{"key":"127_CR40","first-page":"1","volume":"39","author":"LD Wilson","year":"2006","unstructured":"Wilson LD, Jones GW, Smith BD (2006) Cutaneous lymphomas\u2014radiotherapeutic strategies. Front Radiat Ther Oncol 39:1\u201315","journal-title":"Front Radiat Ther Oncol"},{"key":"127_CR41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood-2004-06-2220","volume":"105","author":"C Assaf","year":"2005","unstructured":"Assaf C, Hummel M, Steinhoff M, et al. (2005) Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications. Blood 105:503\u2013510","journal-title":"Blood"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-007-0127-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-007-0127-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-007-0127-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T09:36:20Z","timestamp":1559381780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-007-0127-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,15]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s11307-007-0127-y","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,15]]}}}